Emerging Serological Biomarkers for Autoimmune Hepatitis

Area of Science:

• Immunology
• Hepatology
• Biomarker Discovery

Background:

• Autoimmune hepatitis (AIH) lacks specific diagnostic biomarkers, especially in acute or seronegative cases.
• High-throughput autoantibody profiling enables discovery of novel AIH-associated autoantigens.

Purpose of the Study:

• To review emerging autoantibodies identified via proteome-wide screening for AIH diagnosis.
• To evaluate the diagnostic potential of novel autoantibodies, particularly anti-DOK2 and anti-MRPS27.

Main Methods:

• Proteome-wide screening approaches including human protein microarrays and phage immunoprecipitation sequencing.
• Systematic discovery and validation of novel AIH-associated autoantibodies.

Main Results:

• Emerging autoantibodies, specifically anti-docking protein 2 (DOK2) and anti-mitochondrial ribosomal protein S27 (MRPS27), demonstrate promising diagnostic performance.
• Combined assessment of these autoantibodies significantly enhances diagnostic sensitivity for AIH.
• While improving screening and triage, the reduced specificity limits their use as a standalone confirmatory test.

Conclusions:

• Proteome-wide autoantibody discovery refines diagnostic strategies for AIH.
• Integration of serological biomarkers with molecular pathology advances understanding of AIH pathogenesis.
• Novel autoantibodies offer potential for improved AIH detection and patient management.